… There were no significant differences between the low-molecular-weight heparin group
and aspirin group in the incidence of deep vein thrombosis, hidden blood loss, wound …

… Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or
… bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre …

… Thus, it needs to pick valid treatments to reduce the harm in the clinical treatment. … effects
of rivaroxaban and low molecular heparin on preventing deep venous thrombosis and blood …

… in the in-cidence of deep venous thrombosis between aspirin group and control group (RR: …
in the incidence of pulmonary embolism between aspirin group and control group (RR: 0.91…

… Short-duration prophylaxis against venous thromboembolism after total hip or knee … Xa
inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement[…

随着心血管疾病负担日渐加重， 相关热门领域每年涌现大量研究论文， 其类型多样且涵盖面广。
为了让心血管领域兴趣读者快捷地了解前沿热点， 本文从2019 年度发布的基本科学指标（ ESI） …

… Aspirin isahistorical antiplatelet drug. Now someguidesand researchessuggest it also can
… prevention of venous thromboembolism after arthroplasty. In these researchesꎬ aspirin was …

… of venous thromboembolism for individual patients, in order to reduce the occurrence of
venous thromboembolism and minimize side effects such as bleeding. Recently, aspirin has …

… Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism[J].N En鄄
gl J Med袁2017袁376渊13冤院1211. [5]鲍念念袁张春玲.…

… The hazard of these biases is that suboptimal treatment may ensue: aspirin in patients
who, if found to have AF, could instead have received anticoagulation or left atrial appendage …